Seqens Seqens

X

Find Boric Acid manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
212
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

Tox21_301000
Also known as: Orthoboric acid, 10043-35-3, Boracic acid, Borofax, Boron hydroxide, Boron trihydroxide
Molecular Formula
BH3O3
Molecular Weight
61.84  g/mol
InChI Key
KGBXLFKZBHKPEV-UHFFFAOYSA-N
FDA UNII
R57ZHV85D4

Boric Acid is a weakly acidic hydrate of boric oxide with mild antiseptic, antifungal, and antiviral properties. The exact mechanism of action of boric acid is unknown; generally cytotoxic to all cells. It is used in the treatment of yeast infections and cold sores.
1 2D Structure

Tox21_301000

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
boric acid
2.1.2 InChI
InChI=1S/BH3O3/c2-1(3)4/h2-4H
2.1.3 InChI Key
KGBXLFKZBHKPEV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
B(O)(O)O
2.2 Other Identifiers
2.2.1 UNII
R57ZHV85D4
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Boron Oxide Hydroxide

2. Orthoboric Acid

2.3.2 Depositor-Supplied Synonyms

1. Orthoboric Acid

2. 10043-35-3

3. Boracic Acid

4. Borofax

5. Boron Hydroxide

6. Boron Trihydroxide

7. Three Elephant

8. Boric Acid (bh3o3)

9. Basilit B

10. Trihydroxyborane

11. Trihydroxyborone

12. 11113-50-1

13. Boric Acid (h3bo3)

14. Flea Prufe

15. Super Flea Eliminator

16. Orthoboric Acid (b(oh)3)

17. Orthoborsaeure

18. Borsaeure

19. Borsaure

20. Acidum Boricum

21. Nci-c56417

22. Dr.'s 1 Flea Terminator Dt

23. Boric Acid (van)

24. Bluboro

25. Dr.'s 1 Flea Terminator Dfpbo

26. Dr.'s 1 Flea Terminator Df

27. Collyrium Eye Wash

28. Dr.'s 1 Flea Terminator Dtpbo

29. B(oh)3

30. Boricum Acidum

31. Trihydroxidoboron

32. Ant Flip

33. Homberg's Salt

34. Mfcd00011337

35. Nsc 81726

36. Boric Acid (tn)

37. (10b)orthoboric Acid

38. Nsc-81726

39. Ins No.284

40. R57zhv85d4

41. Chebi:33118

42. Ins-284

43. [b(oh)3]

44. Boric Acid (h(sub 3)bo(sub 3))

45. Ncgc00090745-02

46. Optibor

47. Dsstox_cid_194

48. Orthboric Acid

49. E-284

50. Kjel-sorb™ Solution

51. Dsstox_rid_75425

52. Dsstox_gsid_20194

53. Borsaure [german]

54. Caswell No. 109

55. Boron, Reference Standard Solution

56. Kjel-sorb

57. Kill-off

58. Ortho-boric Acid

59. Boric Acid [usan:jan]

60. Hydrogen Orthoborate

61. Bo3

62. Ccris 855

63. Niban Granular Bait

64. Cas-10043-35-3

65. Hsdb 1432

66. Boric Acid [jan:nf]

67. Boric Acid, Acs

68. Einecs 233-139-2

69. Epa Pesticide Chemical Code 011001

70. Orthoboric Acid (h3bo3)

71. Unii-r57zhv85d4

72. Orthoborc Acd

73. Ai3-02406

74. Boric Acid, Powder

75. Bluboro (salt/mix)

76. Boric Acid, Granular

77. Boric Acid Acs Grade

78. Boric Acid, Puratronic?

79. Wln: Qbqq

80. Boric Acid [ii]

81. Boric Acid [mi]

82. Boric Acid, Acs Reagent

83. Boric Acid [jan]

84. Heptaoxotetra-borate(2-)

85. Bmse000941

86. Boric Acid (jp15/nf)

87. Boric Acid (jp17/nf)

88. Boric Acid [inci]

89. Acidum Boricum (salt/mix)

90. Ec 233-139-2

91. Boric Acid [vandf]

92. Boric Acid, Nf/usp Grade

93. H3bo3

94. Boric Acid [mart.]

95. Boric Acid [usp-rs]

96. Boric Acid [who-dd]

97. Boric Acid, Biochemical Grade

98. Bidd:er0252

99. Boracic Acid, Orthoboric Acid

100. Boricum Acidum [hpus]

101. Chembl42403

102. Boric Acid Electrophoresis Grade

103. Collyrium Eye Wash (salt/mix)

104. Dtxsid1020194

105. Bdbm39817

106. Kgbxlfkzbhkpev-uhfffaoysa-

107. Boric Acid [ep Impurity]

108. Boric Acid [ep Monograph]

109. Boric Acid, 99.9% Metals Basis

110. Bcp21018

111. Boric Acid, 99.99% Metals Basis

112. Boric Acid, Bioxtra, >=99.5%

113. Nsc81726

114. Einecs 237-478-7

115. Tox21_111004

116. Tox21_202185

117. Tox21_301000

118. 1332-77-0 (di-potassium Salt)

119. Bc-140

120. Stl445672

121. Boric Acid, 99.998% Metals Basis

122. Akos015833571

123. Zinc245189278

124. Boric Acid, Acs Reagent, >=99.5%

125. Db11326

126. 11113-50-1;boric Acid;boracic Acid

127. Boric Acid, 99.97% Trace Metals Basis

128. Boric Acid, Usp, 99.5-100.5%

129. Ncgc00090745-01

130. Ncgc00090745-03

131. Ncgc00090745-04

132. Ncgc00090745-05

133. Ncgc00254902-01

134. Ncgc00259734-01

135. Boric Acid, Crude Natural, Containing Not More Than 85 Per Cent Ofh3bo3 Calculated On The Dry Weight

136. Boric Acid, Reagentplus(r), >=99.5%

137. Bp-13473

138. Boric Acid, 99.999% Trace Metals Basis

139. Boric Acid, Saj First Grade, >=99.5%

140. Boric Acid, For Electrophoresis, >=99.5%

141. Boric Acid, Jis Special Grade, >=99.5%

142. B7305

143. Boric Acid, Vetec(tm) Reagent Grade, 98%

144. Ft-0623166

145. Ft-0623167

146. Boric Acid, Tablet, 1 G Boric Acid Per Tablet

147. D01089

148. A800201

149. Q187045

150. J-000132

151. J-523836

152. Boric Acid, >=99.5%, Suitable For Amino Acid Analysis

153. Boric Acid, Nist(r) Srm(r) 951a, Isotopic Standard

154. Boric Acid, Nist(r) Srm(r) 973, Acidimetric Standard

155. Boric Acid, Bioultra, For Molecular Biology, >=99.5% (t)

156. Boric Acid, United States Pharmacopeia (usp) Reference Standard

157. Boric Acid, Cell Culture Tested, Plant Cell Culture Tested, >=99.5%

158. Boric Acid, Biotechnology Performance Certified, >=99.5% (titration), Cell Culture Tested

159. Boric Acid, P.a., Acs Reagent, Reag. Iso, Reag. Ph. Eur., 99.5-100.5%

160. Boron Standard Solution, 1 Mg/ml B, Suitable For Atomic Absorption Spectrometry, 1000 Ppm B

161. Buffer Solution, Ph 11.00 (?0.01 At 25?c), No Color, Specpure?, Nist Traceable

162. Boric Acid, Bioreagent, For Molecular Biology, Suitable For Cell Culture, Suitable For Plant Cell Culture, >=99.5%

163. Boric Acid, Puriss. P.a., Acs Reagent, Reag. Iso, Reag. Ph. Eur., Buffer Substance, >=99.8%

164. Boric Acid, Puriss., Meets Analytical Specification Of Ph. Eur., Bp, Nf, 99.5-100.5%, Powder

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 61.84 g/mol
Molecular Formula BH3O3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass62.0175241 g/mol
Monoisotopic Mass62.0175241 g/mol
Topological Polar Surface Area60.7 Ų
Heavy Atom Count4
Formal Charge0
Complexity8
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

/Former use:/ The substance is included in rectal suppositories for hemorrhoids ...

Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 971


Aqueous solutions of boric acid are used topically for ophthalmic irrigation to cleanse, refresh, and soothe irritated eyes. Aqueous solutions of boric acid also are used for removal of loose foreign material, air pollutants (e.g., smog, pollen), or chlorinated water.

American Society of Health-System Pharmacists 2011; Drug Information 2011. Bethesda, MD. 2011


Boric acid, borates and perborates have been used as mild antiseptics or bacteriostats in eyewashes, mouthwashes, burn dressings, and diaper rash powders; however, the effectiveness of boric acid has largely been discredited.

Seiler, H.G., H. Sigel and A. Sigel (eds.). Handbook on the Toxicity of Inorganic Compounds. New York, NY: Marcel Dekker, Inc. 1988., p. 131


MEDICATION (VET): Antibacterial and antifungal. Used chiefly in aqueous solutions or powders for external use.

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 218


A double-blind comparison was made of the use of 14 daily intravaginal gelatin capsules containing 600 mg of boric acid powder versus the use of identical capsules containing 100,000 U nystatin diluted to volume with cornstarch for the treatment of vulvovaginal candidiasis albicans. Cure rates for boric acid were 92% at 7 to 10 days after treatment and 72% at 30 days, whereas the nystatin cure rates were 64% at 7 to 10 days and 50% at 30 days. The speed of alleviation of signs and symptoms was similar for the two drugs. There were no untoward side effects, and cervical cytologic features were not affected.

PMID:7282789 Van Slyke KK et al; Am J Obstet Gynecol 141 (2): 145-8 (1981)


4.2 Drug Warning

... The chronic use of boric acid in rectal suppositories and in vaginal deodorants carries the risk of intoxication.

Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 971


Borax and boric acid used in powders and ointments have resulted in serious poisonings and death.

Seiler, H.G., H. Sigel and A. Sigel (eds.). Handbook on the Toxicity of Inorganic Compounds. New York, NY: Marcel Dekker, Inc. 1988., p. 135


An outbreak of an illness in a newborn nursery consisting of vomiting, diarrhea, dehydration, and exfoliative dermatitis was mistakenly thought to be due to an infectious agent because Staphylococcus aureus was cultured from the nose, throat, and feces in two patients. The clinical picture was similar to Ritter's disease. However, because S. aureus was not found in other hospital cultures, boric acid toxicity was subsequently considered. It was discovered as a contaminant of the infant formula. Three infants died.

Dart, R.C. (ed). Medical Toxicology. Third Edition, Lippincott Williams & Wilkins. Philadelphia, PA. 2004., p. 1323


Boric acid enhanced action of hypnotics, but devoid of activity itself.

PMID:4440819 Pham Huu Chanh et al; Agressologie 15 (1): 61-72 (1974)


Patients using boric acid ophthalmic solutions should be advised to consult a physician if ocular pain or visual changes occur, they experience continued ocular redness or irritation, or the condition worsens or persists. Patients with open wounds in or near the eyes should be advised to seek immediate medical treatment.

American Society of Health-System Pharmacists 2011; Drug Information 2011. Bethesda, MD. 2011


4.3 Minimum/Potential Fatal Human Dose

The fatal dose /in humans/ is thought to be 2000-3000 mg for infants, 5000-6000 mg for children, and 15,000-20,000 mg for adults.

Krieger, R. (ed.). Handbook of Pesticide Toxicology. Volume 2, 2nd ed. 2001. Academic Press, San Diego, California., p. 1414


4.4 Drug Indication

No FDA- or EMA-approved therapeutic indications on its own.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Boric acid exhibits minimal bacteriostatic and antifungal activities. Boric acid is likely to mediate antifungal actions at high concentrations over prolonged exposures.


5.2 MeSH Pharmacological Classification

Insecticides

Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)


5.3 ATC Code

S - Sensory organs

S02 - Otologicals

S02A - Antiinfectives

S02AA - Antiinfectives

S02AA03 - Boric acid


5.4 Absorption, Distribution and Excretion

Absorption

Boric acid is well absorbed from the gastrointestinal tract, open wounds, and serous cavities but displays limited absorption in intact skin. Following intraperitoneal injection in mice, the peak concentration was reached in about 1.0-1.5 hr in the brain whereas the value was 0.5 hr in other tissues.


Route of Elimination

Regardless the route of administration, boric acid predominantly undergoes rapid renal excretion of >90% of total administered dose as unchanged form. Small amounts are also excreted into sweat, saliva, and feces. Following administration as ointment, urinary excretion of boric acid accounted for only 1% of the administered dose.


Volume of Distribution

Volume of distribution ranges from 0.17 to 0.5 L/kg in humans, where large amounts of boric acid are localized in brain, liver, and kidney.


Clearance

A case report of acute boric acid poisoning following oral ingestion of 21 g of boric acid presents the total body clearance of 0.99 L/h before hemodialysis.


Boric acid is readily absorbed from GI tract, serous cavities, and abraded or inflamed skin. It does not penetrate intact skin. Approximately 50% of given dose is excreted within 24 hr. During chronic administration, plateau in urinary excretion is reached only after 2 wk. ... Large amounts of boric acid are localized in brain, liver, and kidney. ... Intracytoplasmic inclusions in pancreas /have been noted/ in fatal cases. /Boric acid/

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 995


In animals, boric acid has been shown to be readily absorbed from the GI tract. Among the species studied were rats, rabbits, sheep, and cattle.

Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V3 p.535


... Boric acid (5%) was applied topically to 10-15% of the body surface of rabbits with an occlusive dressing for 1.5 hr per day for 4 consecutive days. Minimal amounts of boric acid were absorbed across intact skin and slightly abraded skin of rabbits as measured by excretion of B in urine. Absorption was greater in rabbits with more seriously damaged skin.

Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V3 p.535


In rats given boric acid in an ointment, urinary excretion accounted for only 1% of the administered dose. However, boric acid applied to the skin of rats in an aqueous jelly was absorbed, with 23% of the administered dose appearing in the urine.

Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V3 p.535


For more Absorption, Distribution and Excretion (Complete) data for BORIC ACID (24 total), please visit the HSDB record page.


5.5 Metabolism/Metabolites

No metabolic pathways reported.


Metabolism of inorganic borates by biological systems is not feasible owing to the excessive energy (523 kJ/mol) required to break the boron-oxygen bond. Inorganic borates, in low concentrations, convert to boric acid at physiological pH in the aqueous layer overlying mucosal surfaces prior to absorption. This is supported by the evidence in both human and animal studies, where more than 90% of the administered dose of borate is excreted as boric acid. There is evidence in both in vitro and in vivo systems that boric acid has an affinity for cis-hydroxyl groups, and this may be the mechanism that explains the biological effects of boric acid. However, this attachment is known to be reversible and concentration dependent, responding to clearance mechanisms.

WHO; Environmental Health Criteria 204: Boron p.62 (1998). Available from, as of May 12, 2005: https://www.inchem.org/pages/ehc.html


5.6 Biological Half-Life

According to human cases of poisoning, the elimination half-life of boric acid ranges from 13 to 24 hours.


The kinetics of elimination of boron have been evaluated in human volunteers given boric acid via the intravenous and oral routes. The half-life for elimination was the same by either route in these studies and was approximately 21 hr.

WHO; Environmental Health Criteria 204: Boron p.66 (1998). Available from, as of May 12, 2005: https://www.inchem.org/pages/ehc.html


A mean half-life of 13.4 hours (range, 4 to 28 hours) was reported in nine human cases of poisoning /with boric acid/.

Dart, R.C. (ed). Medical Toxicology. Third Edition, Lippincott Williams & Wilkins. Philadelphia, PA. 2004., p. 1322


In humans, the reported excretion half-life is between 13 and 21 hr.

Krieger, R. (ed.). Handbook of Pesticide Toxicology. Volume 2, 2nd ed. 2001. Academic Press, San Diego, California., p. 1435


The elimination half-life reported for rats is 4.6 hr.

Krieger, R. (ed.). Handbook of Pesticide Toxicology. Volume 2, 2nd ed. 2001. Academic Press, San Diego, California., p. 1435


... Excretion is relatively rapid, occurring over a period of a few to several days, with a half-life of elimination of 24 hr or less.

WHO; Environmental Health Criteria 204: Boron p.66 (1998). Available from, as of May 12, 2005: https://www.inchem.org/pages/ehc.html


5.7 Mechanism of Action

Information regarding the mechanism of action of boric acid in mediating its antibacterial or antifungal actions is limited. Boric acid inhibits biofilm formation and hyphal transformation of _Candida albicans_, which are critical virulence factors. In addition, arrest of fungal growth was observed with the treatment of boric acid.


Boric acid and its derivatives have been shown to promote riboflavinuria in both animals and man. Boric acid complexes with the polyhydroxyl ribitol side chain of riboflavin and greatly increases its water solubility.

PMID:3319474 Pinto JT, Rivlin S; Drug Nutr Interact 5 (3): 143-51 (1987)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY